| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 15 | 2021 | 922 | 3.910 |
Why?
|
| HLA Antigens | 5 | 2021 | 594 | 2.450 |
Why?
|
| Pregnancy | 42 | 2024 | 8125 | 2.020 |
Why?
|
| Pregnancy, Twin | 4 | 2018 | 171 | 1.790 |
Why?
|
| Birth Weight | 6 | 2020 | 355 | 1.470 |
Why?
|
| Pregnancy Outcome | 11 | 2020 | 683 | 1.400 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2016 | 109 | 1.360 |
Why?
|
| Pregnancy Trimesters | 3 | 2018 | 34 | 1.350 |
Why?
|
| Blood Donors | 3 | 2021 | 173 | 1.310 |
Why?
|
| Fetal Weight | 3 | 2020 | 53 | 1.090 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 183 | 0.940 |
Why?
|
| Antibodies | 2 | 2020 | 809 | 0.920 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2023 | 440 | 0.880 |
Why?
|
| Body Mass Index | 5 | 2020 | 2238 | 0.870 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2020 | 59 | 0.860 |
Why?
|
| Arthrogryposis | 2 | 2019 | 34 | 0.850 |
Why?
|
| Trial of Labor | 3 | 2019 | 22 | 0.840 |
Why?
|
| Vaginal Birth after Cesarean | 3 | 2019 | 24 | 0.830 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 121 | 0.820 |
Why?
|
| Limb Deformities, Congenital | 2 | 2019 | 116 | 0.800 |
Why?
|
| Histocompatibility Testing | 5 | 2017 | 487 | 0.760 |
Why?
|
| Fetal Development | 3 | 2018 | 118 | 0.750 |
Why?
|
| Placenta | 5 | 2021 | 561 | 0.750 |
Why?
|
| Transfusion-Related Acute Lung Injury | 1 | 2020 | 9 | 0.750 |
Why?
|
| Heart Defects, Congenital | 5 | 2019 | 1795 | 0.740 |
Why?
|
| Kidney Transplantation | 3 | 2018 | 760 | 0.730 |
Why?
|
| Pregnancy, Multiple | 3 | 2011 | 50 | 0.710 |
Why?
|
| Clubfoot | 1 | 2019 | 25 | 0.690 |
Why?
|
| Polydactyly | 1 | 2019 | 20 | 0.690 |
Why?
|
| Isoantibodies | 4 | 2021 | 120 | 0.680 |
Why?
|
| Plasma | 1 | 2020 | 146 | 0.680 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 232 | 0.680 |
Why?
|
| Fetofetal Transfusion | 2 | 2012 | 187 | 0.660 |
Why?
|
| Chorionic Villi Sampling | 5 | 2019 | 47 | 0.640 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 48 | 0.640 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2020 | 168 | 0.630 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 361 | 0.610 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 199 | 0.600 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 2359 | 0.590 |
Why?
|
| Extremities | 1 | 2019 | 311 | 0.590 |
Why?
|
| Episiotomy | 1 | 2017 | 17 | 0.590 |
Why?
|
| Cervix Uteri | 2 | 2017 | 247 | 0.580 |
Why?
|
| Absorbent Pads | 1 | 2017 | 1 | 0.580 |
Why?
|
| Adipose Tissue | 2 | 2018 | 717 | 0.570 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 522 | 0.560 |
Why?
|
| Professional Staff Committees | 1 | 2016 | 30 | 0.560 |
Why?
|
| Obstetric Labor, Premature | 1 | 2017 | 86 | 0.560 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2016 | 23 | 0.560 |
Why?
|
| Perineum | 1 | 2017 | 115 | 0.550 |
Why?
|
| Amniocentesis | 4 | 2019 | 83 | 0.550 |
Why?
|
| Peer Review | 1 | 2016 | 82 | 0.540 |
Why?
|
| Oxytocics | 1 | 2016 | 33 | 0.540 |
Why?
|
| Allografts | 1 | 2018 | 686 | 0.540 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 15 | 0.530 |
Why?
|
| Fetal Distress | 1 | 2016 | 12 | 0.530 |
Why?
|
| Gestational Age | 6 | 2021 | 1174 | 0.530 |
Why?
|
| Labor, Induced | 1 | 2016 | 36 | 0.530 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 90 | 0.520 |
Why?
|
| Oxytocin | 1 | 2016 | 79 | 0.520 |
Why?
|
| Cesarean Section | 3 | 2021 | 402 | 0.520 |
Why?
|
| Energy Intake | 1 | 2018 | 523 | 0.520 |
Why?
|
| Female | 50 | 2024 | 148967 | 0.520 |
Why?
|
| Statistics as Topic | 1 | 2017 | 453 | 0.510 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 1301 | 0.510 |
Why?
|
| Bradycardia | 1 | 2016 | 73 | 0.510 |
Why?
|
| Microarray Analysis | 4 | 2019 | 397 | 0.510 |
Why?
|
| Heart Rate, Fetal | 1 | 2016 | 64 | 0.510 |
Why?
|
| Gynecology | 2 | 2021 | 235 | 0.510 |
Why?
|
| Graft Survival | 2 | 2018 | 1082 | 0.510 |
Why?
|
| Pertussis Vaccine | 1 | 2015 | 26 | 0.500 |
Why?
|
| Twins | 4 | 2013 | 80 | 0.500 |
Why?
|
| Body Composition | 1 | 2018 | 607 | 0.500 |
Why?
|
| Benchmarking | 1 | 2017 | 275 | 0.500 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 81 | 0.490 |
Why?
|
| Obstetrics | 2 | 2021 | 243 | 0.490 |
Why?
|
| Genotype | 3 | 2017 | 4255 | 0.480 |
Why?
|
| Pneumothorax | 1 | 2016 | 166 | 0.460 |
Why?
|
| Humans | 59 | 2024 | 270802 | 0.460 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 563 | 0.450 |
Why?
|
| Adult | 31 | 2024 | 81997 | 0.440 |
Why?
|
| Proteins | 2 | 2018 | 2043 | 0.440 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 4375 | 0.440 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 418 | 0.430 |
Why?
|
| Delivery, Obstetric | 5 | 2024 | 260 | 0.420 |
Why?
|
| Energy Metabolism | 1 | 2018 | 998 | 0.410 |
Why?
|
| Genotyping Techniques | 3 | 2017 | 164 | 0.410 |
Why?
|
| Infant, Newborn | 10 | 2022 | 8699 | 0.400 |
Why?
|
| Biological Assay | 1 | 2013 | 178 | 0.390 |
Why?
|
| Graft Rejection | 2 | 2018 | 847 | 0.390 |
Why?
|
| Heart-Lung Transplantation | 1 | 2011 | 26 | 0.380 |
Why?
|
| Amniotic Band Syndrome | 3 | 2019 | 25 | 0.380 |
Why?
|
| HLA-B Antigens | 1 | 2011 | 59 | 0.380 |
Why?
|
| Umbilical Cord | 1 | 2011 | 60 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 506 | 0.380 |
Why?
|
| Prenatal Care | 3 | 2020 | 349 | 0.380 |
Why?
|
| Biopsy | 1 | 2018 | 3483 | 0.370 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 4831 | 0.360 |
Why?
|
| Critical Care | 1 | 2016 | 799 | 0.350 |
Why?
|
| Ciliary Motility Disorders | 2 | 2019 | 14 | 0.350 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2019 | 37 | 0.350 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2009 | 18 | 0.340 |
Why?
|
| Basal Metabolism | 2 | 2020 | 86 | 0.330 |
Why?
|
| Encephalocele | 2 | 2019 | 59 | 0.330 |
Why?
|
| Retinitis Pigmentosa | 2 | 2019 | 83 | 0.320 |
Why?
|
| Fertilization in Vitro | 2 | 2021 | 207 | 0.320 |
Why?
|
| Vaccination | 1 | 2015 | 1164 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 908 | 0.320 |
Why?
|
| Placenta Diseases | 1 | 2008 | 61 | 0.310 |
Why?
|
| DNA | 1 | 2016 | 3051 | 0.310 |
Why?
|
| Aneuploidy | 1 | 2009 | 381 | 0.300 |
Why?
|
| Acute Lung Injury | 3 | 2014 | 92 | 0.300 |
Why?
|
| Genetic Testing | 4 | 2019 | 1697 | 0.300 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 117 | 0.300 |
Why?
|
| Obstetric Labor Complications | 1 | 2008 | 99 | 0.300 |
Why?
|
| Tissue Donors | 1 | 2011 | 815 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2012 | 931 | 0.270 |
Why?
|
| Prenatal Diagnosis | 3 | 2021 | 610 | 0.260 |
Why?
|
| Retrospective Studies | 15 | 2024 | 39832 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 585 | 0.250 |
Why?
|
| Perinatology | 2 | 2022 | 30 | 0.240 |
Why?
|
| Megakaryocytes | 1 | 2005 | 129 | 0.240 |
Why?
|
| Receptors, Cytokine | 1 | 2005 | 179 | 0.240 |
Why?
|
| Texas | 4 | 2023 | 6447 | 0.230 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 6193 | 0.230 |
Why?
|
| Enoxaparin | 1 | 2024 | 57 | 0.230 |
Why?
|
| Siblings | 1 | 2005 | 318 | 0.220 |
Why?
|
| RNA Splicing | 1 | 2005 | 361 | 0.220 |
Why?
|
| Alleles | 3 | 2017 | 2602 | 0.220 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2024 | 60 | 0.220 |
Why?
|
| Prospective Studies | 5 | 2018 | 13417 | 0.220 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2019 | 18 | 0.220 |
Why?
|
| Angioedemas, Hereditary | 1 | 2022 | 8 | 0.210 |
Why?
|
| Weight Gain | 2 | 2018 | 472 | 0.210 |
Why?
|
| Transfusion Reaction | 2 | 2014 | 101 | 0.210 |
Why?
|
| Angioedema | 1 | 2022 | 22 | 0.210 |
Why?
|
| Obesity | 2 | 2018 | 2905 | 0.210 |
Why?
|
| Thrombocytopenia | 2 | 2019 | 870 | 0.210 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 5171 | 0.200 |
Why?
|
| Convalescence | 1 | 2020 | 23 | 0.180 |
Why?
|
| Pallister-Hall Syndrome | 1 | 2019 | 3 | 0.180 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2019 | 8 | 0.180 |
Why?
|
| Carpal Bones | 1 | 2019 | 11 | 0.170 |
Why?
|
| Breech Presentation | 1 | 2019 | 21 | 0.170 |
Why?
|
| Radius | 1 | 2019 | 45 | 0.170 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 23 | 0.170 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 46 | 0.170 |
Why?
|
| Thumb | 1 | 2019 | 41 | 0.170 |
Why?
|
| Oligohydramnios | 1 | 2019 | 42 | 0.170 |
Why?
|
| Pierre Robin Syndrome | 1 | 2019 | 29 | 0.170 |
Why?
|
| Minority Groups | 1 | 2022 | 328 | 0.170 |
Why?
|
| Blood Group Incompatibility | 2 | 2016 | 39 | 0.170 |
Why?
|
| Bone Diseases, Developmental | 1 | 2019 | 70 | 0.170 |
Why?
|
| Polyhydramnios | 1 | 2019 | 51 | 0.160 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 658 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 376 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 2394 | 0.160 |
Why?
|
| Body Fluid Compartments | 1 | 2018 | 19 | 0.160 |
Why?
|
| Placenta Accreta | 1 | 2021 | 137 | 0.160 |
Why?
|
| Body Water | 1 | 2018 | 124 | 0.160 |
Why?
|
| Exons | 2 | 2017 | 1381 | 0.160 |
Why?
|
| Sex Distribution | 1 | 2019 | 497 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2024 | 775 | 0.160 |
Why?
|
| Cerclage, Cervical | 1 | 2018 | 11 | 0.150 |
Why?
|
| Pregnancy Reduction, Multifetal | 2 | 2008 | 21 | 0.150 |
Why?
|
| Apgar Score | 1 | 2018 | 55 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 188 | 0.150 |
Why?
|
| Health Information Interoperability | 1 | 2017 | 4 | 0.150 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 186 | 0.150 |
Why?
|
| Algorithms | 1 | 2009 | 3900 | 0.150 |
Why?
|
| Case-Control Studies | 5 | 2020 | 6237 | 0.150 |
Why?
|
| Body Height | 1 | 2018 | 234 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2022 | 727 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2016 | 6768 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2013 | 424 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 423 | 0.140 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2016 | 14 | 0.140 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2016 | 16 | 0.140 |
Why?
|
| Postpartum Period | 1 | 2018 | 261 | 0.140 |
Why?
|
| Inservice Training | 1 | 2017 | 74 | 0.140 |
Why?
|
| Cell-Free System | 1 | 2016 | 175 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2017 | 218 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 159 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2016 | 74 | 0.140 |
Why?
|
| Maternal Mortality | 1 | 2017 | 81 | 0.140 |
Why?
|
| Reference Values | 1 | 2018 | 1134 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 291 | 0.130 |
Why?
|
| Male | 12 | 2021 | 128397 | 0.130 |
Why?
|
| Gene Library | 1 | 2017 | 353 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 91 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 2618 | 0.130 |
Why?
|
| False Positive Reactions | 1 | 2016 | 376 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2019 | 392 | 0.130 |
Why?
|
| Labor, Obstetric | 1 | 2016 | 99 | 0.130 |
Why?
|
| Directive Counseling | 1 | 2015 | 41 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 416 | 0.120 |
Why?
|
| Betacoronavirus | 1 | 2020 | 513 | 0.120 |
Why?
|
| Sacrum | 1 | 2016 | 138 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 90 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2022 | 914 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 247 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 146 | 0.120 |
Why?
|
| Hypotension | 1 | 2016 | 232 | 0.110 |
Why?
|
| Living Donors | 1 | 2014 | 175 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 4963 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 552 | 0.110 |
Why?
|
| Histocompatibility | 1 | 2013 | 183 | 0.100 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 625 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 825 | 0.100 |
Why?
|
| Preconception Care | 1 | 2012 | 19 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 700 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2012 | 30 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 189 | 0.100 |
Why?
|
| Postnatal Care | 1 | 2012 | 51 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2016 | 632 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 1442 | 0.100 |
Why?
|
| Prognosis | 2 | 2019 | 22481 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 89 | 0.100 |
Why?
|
| Abortion, Induced | 1 | 2012 | 94 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2017 | 2363 | 0.100 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 535 | 0.090 |
Why?
|
| Middle Aged | 8 | 2021 | 90347 | 0.090 |
Why?
|
| Time Factors | 3 | 2016 | 13021 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 211 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 3478 | 0.090 |
Why?
|
| Pandemics | 1 | 2020 | 1610 | 0.090 |
Why?
|
| Genome, Human | 1 | 2019 | 1886 | 0.090 |
Why?
|
| Exercise | 1 | 2018 | 1207 | 0.090 |
Why?
|
| Software | 1 | 2017 | 1356 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 391 | 0.090 |
Why?
|
| Decision Making | 1 | 2017 | 1251 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 822 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2015 | 1155 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 2573 | 0.080 |
Why?
|
| Risk Factors | 4 | 2020 | 17900 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2019 | 2767 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2018 | 1302 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2008 | 170 | 0.080 |
Why?
|
| Nose | 1 | 2009 | 141 | 0.080 |
Why?
|
| Fetal Monitoring | 1 | 2008 | 57 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2012 | 456 | 0.080 |
Why?
|
| Maternal Age | 1 | 2008 | 147 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 95 | 0.070 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2007 | 7 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2007 | 67 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 464 | 0.070 |
Why?
|
| Pregnancy, Ectopic | 1 | 2007 | 37 | 0.070 |
Why?
|
| Young Adult | 7 | 2019 | 22225 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2011 | 677 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2019 | 9474 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2013 | 897 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 484 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 883 | 0.060 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2005 | 79 | 0.060 |
Why?
|
| Blood Cell Count | 1 | 2005 | 233 | 0.060 |
Why?
|
| Mutation | 1 | 2005 | 15911 | 0.060 |
Why?
|
| Thrombopoietin | 1 | 2005 | 102 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 461 | 0.060 |
Why?
|
| Prevalence | 1 | 2012 | 3402 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 73382 | 0.060 |
Why?
|
| Anemia, Aplastic | 1 | 2005 | 232 | 0.060 |
Why?
|
| Methotrexate | 1 | 2007 | 1025 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 31008 | 0.060 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 8 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7895 | 0.050 |
Why?
|
| United States | 4 | 2022 | 15855 | 0.050 |
Why?
|
| Pedigree | 1 | 2005 | 2042 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 188 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5676 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 681 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 15212 | 0.050 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2019 | 6 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2019 | 10 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2005 | 1857 | 0.040 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 15 | 0.040 |
Why?
|
| Gambia | 1 | 2019 | 28 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 2357 | 0.040 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2019 | 20 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2019 | 99 | 0.040 |
Why?
|
| Child | 4 | 2022 | 30546 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 90 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 29 | 0.040 |
Why?
|
| South America | 1 | 2019 | 54 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 188 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 374 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 236 | 0.040 |
Why?
|
| Survival Rate | 1 | 2012 | 12527 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 128 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 275 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2019 | 274 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 71 | 0.040 |
Why?
|
| Spine | 1 | 2019 | 312 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 5339 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 1129 | 0.040 |
Why?
|
| Disease | 1 | 2019 | 165 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 338 | 0.040 |
Why?
|
| Trachea | 1 | 2019 | 298 | 0.040 |
Why?
|
| Gene Expression | 1 | 2005 | 3642 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2019 | 366 | 0.030 |
Why?
|
| Myosarcoma | 1 | 2016 | 3 | 0.030 |
Why?
|
| Esophagus | 1 | 2019 | 563 | 0.030 |
Why?
|
| Live Birth | 1 | 2016 | 59 | 0.030 |
Why?
|
| Ilium | 1 | 2016 | 55 | 0.030 |
Why?
|
| Adolescent | 4 | 2022 | 32743 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2019 | 411 | 0.030 |
Why?
|
| Uterus | 1 | 2021 | 798 | 0.030 |
Why?
|
| Time | 1 | 2016 | 183 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Robotics | 1 | 2018 | 365 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2014 | 125 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 667 | 0.030 |
Why?
|
| Myocardium | 1 | 2019 | 1233 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 1023 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 13989 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2014 | 267 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2022 | 17048 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 153 | 0.020 |
Why?
|
| Kidney | 1 | 2019 | 2121 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 2165 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2013 | 533 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 1313 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2011 | 581 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 646 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 5 | 0.020 |
Why?
|
| Amnion | 1 | 2007 | 42 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 4328 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2007 | 64 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 286 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 1431 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4213 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 1689 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6255 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 5828 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 5060 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 3448 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 33741 | 0.010 |
Why?
|